Your browser doesn't support javascript.
loading
The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure.
Ratajczak, Blazej; Przybylowicz-Chalecka, Anna; Czerwinska-Rybak, Joanna; Kandula, Zuzanna; Ustaszewski, Adam; Gil, Lidia; Lewandowski, Krzysztof; Jarmuz-Szymczak, Malgorzata.
Afiliación
  • Ratajczak B; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: blazejratajczak@icloud.com.
  • Przybylowicz-Chalecka A; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Czerwinska-Rybak J; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Kandula Z; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Ustaszewski A; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Gil L; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Lewandowski K; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Jarmuz-Szymczak M; Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Leuk Res ; 132: 107349, 2023 09.
Article en En | MEDLINE | ID: mdl-37393627

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Res Año: 2023 Tipo del documento: Article